Dose determination and pharmacokinetics (PK) of pralsetinib: Results from the phase I ARROW study

Authors

• M S. Brose

Publication/Presentation Date

4-2022

Volume

33

Issue

2

First Page

44

Last Page

44

Published In/Presented At

https://doi.org/10.1016/j.annonc.2022.02.037

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article